ReP USP - Resultado da busca

Artigo de periodico
Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial (2023)
Lepski, Guilherme ; Bergami-Santos, Patricia C. ; Pinho, Mariana P. ; Chauca-Torres, Nadia E. ; Evangelista, Gabriela C. M. ; Teixeira, Sarah F. ; Flatow, Elizabeth ; Oliveira, Jaqueline V. de ; Fogolin, Carla ; Peres, Nataly ; Arévalo, Analía ; Alves, Venâncio A. F. ; Barbuto, José Alexandre Marzagão
Fonte: Cancers. Unidades: FM, ICB
Assuntos: IMUNOLOGIA, NEOPLASIAS CEREBRAIS, GLIOMA, IMUNOTERAPIA, ADJUVANTES IMUNOLÓGICOS, CÉLULAS DENDRÍTICAS, ASTROCITOMA, CÉLULAS CULTIVADAS DE TUMOR, VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEPSKI, Guilherme et al. Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial. Cancers, v. 15, n. 4, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15041239. Acesso em: 04 jun. 2024.
APA
Lepski, G., Bergami-Santos, P. C., Pinho, M. P., Chauca-Torres, N. E., Evangelista, G. C. M., Teixeira, S. F., et al. (2023). Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial. Cancers, 15( 4), 1-12. doi:10.3390/cancers15041239
NLM
Lepski G, Bergami-Santos PC, Pinho MP, Chauca-Torres NE, Evangelista GCM, Teixeira SF, Flatow E, Oliveira JV de, Fogolin C, Peres N, Arévalo A, Alves VAF, Barbuto JAM. Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial [Internet]. Cancers. 2023 ; 15( 4): 1-12.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3390/cancers15041239
Vancouver
Lepski G, Bergami-Santos PC, Pinho MP, Chauca-Torres NE, Evangelista GCM, Teixeira SF, Flatow E, Oliveira JV de, Fogolin C, Peres N, Arévalo A, Alves VAF, Barbuto JAM. Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial [Internet]. Cancers. 2023 ; 15( 4): 1-12.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3390/cancers15041239
Trabalho de evento-resumo
Nanoparticles for therapeutic delivery of exosomes: a new approach to immunotherapy against glioblastoma (2022)
Oliveira, Jaqueline Vaz de ; Ferreira, Leonardo Miziara Barboza; Zucolotto, Valtencir ; Barbuto, José Alexandre Marzagão
Fonte: Program. Nome do evento: Brazil MRS Meeting. Unidades: IFSC, ICB
Assuntos: BIOMEDICINA, NANOTECNOLOGIA, TOXICOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Jaqueline Vaz de et al. Nanoparticles for therapeutic delivery of exosomes: a new approach to immunotherapy against glioblastoma. 2022, Anais.. Rio de Janeiro: Sociedade Brasileira de Pesquisa em Materiais - SBPMat, 2022. Disponível em: https://repositorio.usp.br/directbitstream/5701084e-6116-47a0-bacd-cde48c96a04d/3095769.pdf. Acesso em: 04 jun. 2024.
APA
Oliveira, J. V. de, Ferreira, L. M. B., Zucolotto, V., & Barbuto, J. A. M. (2022). Nanoparticles for therapeutic delivery of exosomes: a new approach to immunotherapy against glioblastoma. In Program. Rio de Janeiro: Sociedade Brasileira de Pesquisa em Materiais - SBPMat. Recuperado de https://repositorio.usp.br/directbitstream/5701084e-6116-47a0-bacd-cde48c96a04d/3095769.pdf
NLM
Oliveira JV de, Ferreira LMB, Zucolotto V, Barbuto JAM. Nanoparticles for therapeutic delivery of exosomes: a new approach to immunotherapy against glioblastoma [Internet]. Program. 2022 ;[citado 2024 jun. 04 ] Available from: https://repositorio.usp.br/directbitstream/5701084e-6116-47a0-bacd-cde48c96a04d/3095769.pdf
Vancouver
Oliveira JV de, Ferreira LMB, Zucolotto V, Barbuto JAM. Nanoparticles for therapeutic delivery of exosomes: a new approach to immunotherapy against glioblastoma [Internet]. Program. 2022 ;[citado 2024 jun. 04 ] Available from: https://repositorio.usp.br/directbitstream/5701084e-6116-47a0-bacd-cde48c96a04d/3095769.pdf
Artigo de periodico
Near-complete remission of Glioblastoma in a patient treated with an allogenic dendritic cell-based vaccine: the role of tumor-specific CD4+T-cell cytokine secretion pattern in predicting response and recurrence (2022)
Pinho, Mariana Pereira ; Lepski, Guilherme Alves; Rehder, Roberta ; Torres, Nadia Emely Chauca ; Evangelista, Gabriela Coeli Menezes ; Teixeira, Sarah Fernandes ; Flatow, Elizabeth Alexandra ; Oliveira, Jaqueline Vaz de ; Fogolin, Carla Sanzochi ; Bento, Nataly Peres Carvalho ; Arévalo, Analía Leonora ; Alves, Venâncio Avancini Ferreira ; Barbuto, José Alexandre Marzagão ; Santos, Patricia Cruz Bergami
Fonte: International Journal of Molecular Sciences. Unidades: FM, ICB
Assuntos: IMUNOLOGIA, IMUNOTERAPIA, LINFÓCITOS T, NEOPLASIAS CEREBRAIS, VACINAS, CITOCINAS, IMUNOPROTEINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINHO, Mariana Pereira et al. Near-complete remission of Glioblastoma in a patient treated with an allogenic dendritic cell-based vaccine: the role of tumor-specific CD4+T-cell cytokine secretion pattern in predicting response and recurrence. International Journal of Molecular Sciences, v. 23, n. 10, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.3390/ijms23105396. Acesso em: 04 jun. 2024.
APA
Pinho, M. P., Lepski, G. A., Rehder, R., Torres, N. E. C., Evangelista, G. C. M., Teixeira, S. F., et al. (2022). Near-complete remission of Glioblastoma in a patient treated with an allogenic dendritic cell-based vaccine: the role of tumor-specific CD4+T-cell cytokine secretion pattern in predicting response and recurrence. International Journal of Molecular Sciences, 23( 10), 1-10. doi:10.3390/ijms23105396
NLM
Pinho MP, Lepski GA, Rehder R, Torres NEC, Evangelista GCM, Teixeira SF, Flatow EA, Oliveira JV de, Fogolin CS, Bento NPC, Arévalo AL, Alves VAF, Barbuto JAM, Santos PCB. Near-complete remission of Glioblastoma in a patient treated with an allogenic dendritic cell-based vaccine: the role of tumor-specific CD4+T-cell cytokine secretion pattern in predicting response and recurrence [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 10): 1-10.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3390/ijms23105396
Vancouver
Pinho MP, Lepski GA, Rehder R, Torres NEC, Evangelista GCM, Teixeira SF, Flatow EA, Oliveira JV de, Fogolin CS, Bento NPC, Arévalo AL, Alves VAF, Barbuto JAM, Santos PCB. Near-complete remission of Glioblastoma in a patient treated with an allogenic dendritic cell-based vaccine: the role of tumor-specific CD4+T-cell cytokine secretion pattern in predicting response and recurrence [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 10): 1-10.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3390/ijms23105396
Artigo de periodico
Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states (2022)
Schimke, Lena Friederike ; Marques, Alexandre Henrique Carvalho ; Baiocchi, Gabriela Crispim ; Prado, Caroline Aliane de Souza ; Fonseca, Dennyson Leandro Mathias da; Freire, Paula Paccielli ; Plaça, Desirée Rodrigues ; Filgueiras, Igor Salerno ; Salgado, Ranieri Coelho ; Marques, Gabriel Jansen; Oliveira, Antonio Edson Rocha ; Peron, Jean Pierre Schatzmann ; Miranda, Gustavo Cabral; Barbuto, José Alexandre Marzagão ; Câmara, Niels Olsen Saraiva ; Calich, Vera Lúcia Garcia ; Ochs, Hans D.; Condino Neto, Antonio ; Nakaya, Helder Takashi Imoto ; Overmyer, Katherine A.; Coon, Joshua J.
Fonte: Cells. Unidades: ICB, BIOTECNOLOGIA, FCF, EACH
Assuntos: IMUNOLOGIA, COVID-19, EXPRESSÃO GÊNICA, TRANSCRIÇÃO GÊNICA, NEUTRÓFILOS, COVID-19, INFLAMAÇÃO, CITOCINAS, QUIMIOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHIMKE, Lena Friederike et al. Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states. Cells, v. 11, n. 5, p. 1-24, 2022Tradução . . Disponível em: https://doi.org/10.3390/cells11050847. Acesso em: 04 jun. 2024.
APA
Schimke, L. F., Marques, A. H. C., Baiocchi, G. C., Prado, C. A. de S., Fonseca, D. L. M. da, Freire, P. P., et al. (2022). Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states. Cells, 11( 5), 1-24. doi:10.3390/cells11050847
NLM
Schimke LF, Marques AHC, Baiocchi GC, Prado CA de S, Fonseca DLM da, Freire PP, Plaça DR, Filgueiras IS, Salgado RC, Marques GJ, Oliveira AER, Peron JPS, Miranda GC, Barbuto JAM, Câmara NOS, Calich VLG, Ochs HD, Condino Neto A, Nakaya HTI, Overmyer KA, Coon JJ. Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states [Internet]. Cells. 2022 ; 11( 5): 1-24.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3390/cells11050847
Vancouver
Schimke LF, Marques AHC, Baiocchi GC, Prado CA de S, Fonseca DLM da, Freire PP, Plaça DR, Filgueiras IS, Salgado RC, Marques GJ, Oliveira AER, Peron JPS, Miranda GC, Barbuto JAM, Câmara NOS, Calich VLG, Ochs HD, Condino Neto A, Nakaya HTI, Overmyer KA, Coon JJ. Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states [Internet]. Cells. 2022 ; 11( 5): 1-24.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3390/cells11050847
Artigo de periodico
The war is on: the Immune System against Glioblastoma—how can NK cells drive this battle? (2022)
Silva, Lucas Henrique Rodrigues da ; Catharino, Luana Correia Croda; Silva, Viviane Jennifer da ; Evangelista, Gabriela Coeli Menezes ; Barbuto, José Alexandre Marzagão
Fonte: Biomedicines. Unidades: ICB, FCF, FM
Assuntos: IMUNOLOGIA, GLIOMA, NEOPLASIAS CEREBRAIS, CÉLULAS CULTIVADAS DE TUMOR, CITOTOXICIDADE IMUNOLÓGICA, LINFÓCITOS, CITOCINAS, METÁSTASE LINFÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Lucas Henrique Rodrigues da et al. The war is on: the Immune System against Glioblastoma—how can NK cells drive this battle?. Biomedicines, v. 10, n. 2, p. 1-41, 2022Tradução . . Disponível em: https://doi.org/10.3390/biomedicines10020400. Acesso em: 04 jun. 2024.
APA
Silva, L. H. R. da, Catharino, L. C. C., Silva, V. J. da, Evangelista, G. C. M., & Barbuto, J. A. M. (2022). The war is on: the Immune System against Glioblastoma—how can NK cells drive this battle? Biomedicines, 10( 2), 1-41. doi:10.3390/biomedicines10020400
NLM
Silva LHR da, Catharino LCC, Silva VJ da, Evangelista GCM, Barbuto JAM. The war is on: the Immune System against Glioblastoma—how can NK cells drive this battle? [Internet]. Biomedicines. 2022 ; 10( 2): 1-41.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3390/biomedicines10020400
Vancouver
Silva LHR da, Catharino LCC, Silva VJ da, Evangelista GCM, Barbuto JAM. The war is on: the Immune System against Glioblastoma—how can NK cells drive this battle? [Internet]. Biomedicines. 2022 ; 10( 2): 1-41.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3390/biomedicines10020400
Trabalho de evento-resumo
Nanoparticles for therapeutic delivery of exosomes: a new approach to immunotherapy against glioblastoma (2022)
Oliveira, Jaqueline Vaz de ; Ferreira, Leonardo Miziara Barboza; Zucolotto, Valtencir ; Barbuto, José Alexandre Marzagão
Fonte: Final program. Nome do evento: Congress of the Brazilian Society for Cell Biology. Unidades: IFSC, ICB
Assuntos: NEOPLASIAS CEREBRAIS, NANOPARTÍCULAS, IMUNOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Jaqueline Vaz de et al. Nanoparticles for therapeutic delivery of exosomes: a new approach to immunotherapy against glioblastoma. 2022, Anais.. São Paulo: Sociedade Brasileira de Biologia Celular - SBBC, 2022. Disponível em: https://www.sbbc.org.br/wp-content/uploads/2023/01/Final_program_sbbc2022_v1.pdf. Acesso em: 04 jun. 2024.
APA
Oliveira, J. V. de, Ferreira, L. M. B., Zucolotto, V., & Barbuto, J. A. M. (2022). Nanoparticles for therapeutic delivery of exosomes: a new approach to immunotherapy against glioblastoma. In Final program. São Paulo: Sociedade Brasileira de Biologia Celular - SBBC. Recuperado de https://www.sbbc.org.br/wp-content/uploads/2023/01/Final_program_sbbc2022_v1.pdf
NLM
Oliveira JV de, Ferreira LMB, Zucolotto V, Barbuto JAM. Nanoparticles for therapeutic delivery of exosomes: a new approach to immunotherapy against glioblastoma [Internet]. Final program. 2022 ;[citado 2024 jun. 04 ] Available from: https://www.sbbc.org.br/wp-content/uploads/2023/01/Final_program_sbbc2022_v1.pdf
Vancouver
Oliveira JV de, Ferreira LMB, Zucolotto V, Barbuto JAM. Nanoparticles for therapeutic delivery of exosomes: a new approach to immunotherapy against glioblastoma [Internet]. Final program. 2022 ;[citado 2024 jun. 04 ] Available from: https://www.sbbc.org.br/wp-content/uploads/2023/01/Final_program_sbbc2022_v1.pdf
Artigo de periodico
VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants (2021)
Syed, Wasim Aluisio Prates ; Chaves, Lorena C. S. ; Crema, Karin Paola; Vuitika, Larissa; Lira, Aline ; Cortês, Nelson de Angelis ; Kersten, Victor; Guimarães, Francisco Eduardo Gontijo ; Sadraeian, Mohammad ; Silva, Fernando Luís Barroso da ; Cabral-Marques, Otávio ; Barbuto, José Alexandre Marzagão ; Russo, Momtchilo ; Câmara, Niels Olsen Saraiva ; Miranda, Gustavo Cabral de
Fonte: Vaccines. Unidades: IFSC, FCFRP, ICB, BIOTECNOLOGIA
Assuntos: COVID-19, CORONAVIRUS, VACINAS VIRAIS, IMUNOLOGIA, VARIAÇÃO GENÉTICA, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SYED, Wasim Aluisio Prates et al. VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants. Vaccines, v. 9, n. 12, p. 1409-1-1409-17, 2021Tradução . . Disponível em: https://doi.org/10.3390/vaccines9121409. Acesso em: 04 jun. 2024.
APA
Syed, W. A. P., Chaves, L. C. S., Crema, K. P., Vuitika, L., Lira, A., Cortês, N. de A., et al. (2021). VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants. Vaccines, 9( 12), 1409-1-1409-17. doi:10.3390/vaccines9121409
NLM
Syed WAP, Chaves LCS, Crema KP, Vuitika L, Lira A, Cortês N de A, Kersten V, Guimarães FEG, Sadraeian M, Silva FLB da, Cabral-Marques O, Barbuto JAM, Russo M, Câmara NOS, Miranda GC de. VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants [Internet]. Vaccines. 2021 ; 9( 12): 1409-1-1409-17.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3390/vaccines9121409
Vancouver
Syed WAP, Chaves LCS, Crema KP, Vuitika L, Lira A, Cortês N de A, Kersten V, Guimarães FEG, Sadraeian M, Silva FLB da, Cabral-Marques O, Barbuto JAM, Russo M, Câmara NOS, Miranda GC de. VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants [Internet]. Vaccines. 2021 ; 9( 12): 1409-1-1409-17.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3390/vaccines9121409
Artigo de periodico
Myeloid immune cells CARrying a new weapon against Cancer (2021)
Ramos, Rodrigo Nalio ; Couto, Samuel Campanelli Freitas ; Oliveira, Theo Gremen Mimary ; Klinger, Paulo Henriqe dos Santos ; Braga, Tarcio Teodoro ; Rego, Eduardo Magalhães ; Barbuto, José Alexandre Marzagão ; Rocha, Vanderson Geraldo
Fonte: Frontiers in Cell and Developmental Biology. Unidades: ICB, FM
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMOS, Rodrigo Nalio et al. Myeloid immune cells CARrying a new weapon against Cancer. Frontiers in Cell and Developmental Biology, v. 9, p. 1-17, 2021Tradução . . Disponível em: https://doi.org/10.3389/fcell.2021.784421. Acesso em: 04 jun. 2024.
APA
Ramos, R. N., Couto, S. C. F., Oliveira, T. G. M., Klinger, P. H. dos S., Braga, T. T., Rego, E. M., et al. (2021). Myeloid immune cells CARrying a new weapon against Cancer. Frontiers in Cell and Developmental Biology, 9, 1-17. doi:10.3389/fcell.2021.784421
NLM
Ramos RN, Couto SCF, Oliveira TGM, Klinger PH dos S, Braga TT, Rego EM, Barbuto JAM, Rocha VG. Myeloid immune cells CARrying a new weapon against Cancer [Internet]. Frontiers in Cell and Developmental Biology. 2021 ; 9 1-17.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3389/fcell.2021.784421
Vancouver
Ramos RN, Couto SCF, Oliveira TGM, Klinger PH dos S, Braga TT, Rego EM, Barbuto JAM, Rocha VG. Myeloid immune cells CARrying a new weapon against Cancer [Internet]. Frontiers in Cell and Developmental Biology. 2021 ; 9 1-17.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3389/fcell.2021.784421
Artigo de periodico
Macrophage inflammatory state in type 1 diabetes: triggered by NLRP3/iNOS pathway and attenuated by docosahexaenoic acid (DHA) (2020)
Davanso, Mariana Rodrigues ; Crisma, Amanda Rabello ; Braga, Tarcio Teodoro ; Masi, Laureane Nunes ; Amaral, Catia Lira do ; Leal, Vinicius Nunes Cordeiro ; Lima, Dhêmerson Souza de ; Patente, Thiago Andrade ; Giannella, Maria Lucia Correa ; Lauterbach, Mario ; Kolbe, Carl Christian ; Latz, Eicke ; Barbuto, José Alexandre Marzagão ; Câmara, Niels Olsen Saraiva ; Pontillo, Alessandra ; Curi, Rui
Fonte: Clinical Science (Online): an international journal of translational science and medicine. Unidade: ICB
Assuntos: FISIOLOGIA, IMUNOLOGIA, DIABETES MELLITUS, ÁCIDOS GRAXOS, MACRÓFAGOS, INFLAMAÇÃO, DOENÇAS AUTOIMUNES, ILHOTAS DE LANGERHANS, MONÓCITOS, HIPERGLICEMIA, CITOCINAS, ÓXIDO NÍTRICO, MODELOS ANIMAIS DE DOENÇAS, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAVANSO, Mariana Rodrigues et al. Macrophage inflammatory state in type 1 diabetes: triggered by NLRP3/iNOS pathway and attenuated by docosahexaenoic acid (DHA). Clinical Science (Online): an international journal of translational science and medicine, p. [29 ], 2020Tradução . . Disponível em: https://doi.org/10.1042/CS20201348. Acesso em: 04 jun. 2024.
APA
Davanso, M. R., Crisma, A. R., Braga, T. T., Masi, L. N., Amaral, C. L. do, Leal, V. N. C., et al. (2020). Macrophage inflammatory state in type 1 diabetes: triggered by NLRP3/iNOS pathway and attenuated by docosahexaenoic acid (DHA). Clinical Science (Online): an international journal of translational science and medicine, [29 ]. doi:10.1042/CS20201348
NLM
Davanso MR, Crisma AR, Braga TT, Masi LN, Amaral CL do, Leal VNC, Lima DS de, Patente TA, Giannella MLC, Lauterbach M, Kolbe CC, Latz E, Barbuto JAM, Câmara NOS, Pontillo A, Curi R. Macrophage inflammatory state in type 1 diabetes: triggered by NLRP3/iNOS pathway and attenuated by docosahexaenoic acid (DHA) [Internet]. Clinical Science (Online): an international journal of translational science and medicine. 2020 ;[29 ].[citado 2024 jun. 04 ] Available from: https://doi.org/10.1042/CS20201348
Vancouver
Davanso MR, Crisma AR, Braga TT, Masi LN, Amaral CL do, Leal VNC, Lima DS de, Patente TA, Giannella MLC, Lauterbach M, Kolbe CC, Latz E, Barbuto JAM, Câmara NOS, Pontillo A, Curi R. Macrophage inflammatory state in type 1 diabetes: triggered by NLRP3/iNOS pathway and attenuated by docosahexaenoic acid (DHA) [Internet]. Clinical Science (Online): an international journal of translational science and medicine. 2020 ;[29 ].[citado 2024 jun. 04 ] Available from: https://doi.org/10.1042/CS20201348
Artigo de periodico
Immunomodulatory protective effects of Rb9 cyclic-peptide in a metastatic melanoma setting and the involvement of dendritic cells (2020)
Machado, Fabrício Castro; Girola, Natália; Maia, Vera Susana Carneiro; Santos, Patricia Cruz Bergami; Morais, Alice Santana ; Azevedo, Ricardo Alexandre ; Figueiredo, Carlos Rogerio de ; Barbuto, José Alexandre Marzagão ; Travassos, Luiz Rodolpho Raja Gabaglia
Fonte: Frontiers in Immunology. Unidade: ICB
Assuntos: IMUNOLOGIA, CÉLULAS DENDRÍTICAS, PROLIFERAÇÃO CELULAR, MACRÓFAGOS, LINFÓCITOS, MELANOMA, ADJUVANTES IMUNOLÓGICOS, METÁSTASE ANIMAL, CAMUNDONGOS, PEPTÍDEOS CÍCLICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Fabrício Castro et al. Immunomodulatory protective effects of Rb9 cyclic-peptide in a metastatic melanoma setting and the involvement of dendritic cells. Frontiers in Immunology, v. 10, p. 20 , 2020Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2019.03122. Acesso em: 04 jun. 2024.
APA
Machado, F. C., Girola, N., Maia, V. S. C., Santos, P. C. B., Morais, A. S., Azevedo, R. A., et al. (2020). Immunomodulatory protective effects of Rb9 cyclic-peptide in a metastatic melanoma setting and the involvement of dendritic cells. Frontiers in Immunology, 10, 20 . doi:10.3389/fimmu.2019.03122
NLM
Machado FC, Girola N, Maia VSC, Santos PCB, Morais AS, Azevedo RA, Figueiredo CR de, Barbuto JAM, Travassos LRRG. Immunomodulatory protective effects of Rb9 cyclic-peptide in a metastatic melanoma setting and the involvement of dendritic cells [Internet]. Frontiers in Immunology. 2020 ; 10 20 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.3389/fimmu.2019.03122
Vancouver
Machado FC, Girola N, Maia VSC, Santos PCB, Morais AS, Azevedo RA, Figueiredo CR de, Barbuto JAM, Travassos LRRG. Immunomodulatory protective effects of Rb9 cyclic-peptide in a metastatic melanoma setting and the involvement of dendritic cells [Internet]. Frontiers in Immunology. 2020 ; 10 20 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.3389/fimmu.2019.03122
Artigo de periodico
Laminin-derived peptide C16 regulates Tks expression and reactive oxygen species generation in human prostate cancer cells. (2020)
Santos, Livia Caire do; Silva, Suély Vieira da; Smuczek, Basilio; Siqueira, Adriane Souza de ; Augusto, Taize Machado ; Carvalho, Hernandes Fautino de ; Jaeger, Ruy Gastaldoni ; Freitas, Vanessa Morais ; Barbuto, José Alexandre Marzagão
Fonte: Journal of Cellular Physiology. Unidade: ICB
Assuntos: BIOLOGIA CELULAR, IMUNOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, REGULAÇÃO GÊNICA, CITOMETRIA DE FLUXO, PRÓSTATA, FLUORESCÊNCIA, PEPTÍDEOS, NEOPLASIAS PROSTÁTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Livia Caire do et al. Laminin-derived peptide C16 regulates Tks expression and reactive oxygen species generation in human prostate cancer cells. Journal of Cellular Physiology, v. 235, p. 587-598, 2020Tradução . . Disponível em: https://doi.org/10.1002/jcp.28997. Acesso em: 04 jun. 2024.
APA
Santos, L. C. do, Silva, S. V. da, Smuczek, B., Siqueira, A. S. de, Augusto, T. M., Carvalho, H. F. de, et al. (2020). Laminin-derived peptide C16 regulates Tks expression and reactive oxygen species generation in human prostate cancer cells. Journal of Cellular Physiology, 235, 587-598. doi:10.1002/jcp.28997
NLM
Santos LC do, Silva SV da, Smuczek B, Siqueira AS de, Augusto TM, Carvalho HF de, Jaeger RG, Freitas VM, Barbuto JAM. Laminin-derived peptide C16 regulates Tks expression and reactive oxygen species generation in human prostate cancer cells. [Internet]. Journal of Cellular Physiology. 2020 ; 235 587-598.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1002/jcp.28997
Vancouver
Santos LC do, Silva SV da, Smuczek B, Siqueira AS de, Augusto TM, Carvalho HF de, Jaeger RG, Freitas VM, Barbuto JAM. Laminin-derived peptide C16 regulates Tks expression and reactive oxygen species generation in human prostate cancer cells. [Internet]. Journal of Cellular Physiology. 2020 ; 235 587-598.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1002/jcp.28997
Artigo de periodico
Combined p14ARF and interferon-β gene transfer to the human melanoma cell line SK-MEL-147 promotes oncolysis and immune activation (2020)
Cerqueira, Otto Luiz Dutra; Salomon, Maria Alejandra Clavijo ; Cardoso, Elaine Cristina; Tortelli Junior, Tharcisio Citrangulo ; Mendonça, Samir Andrade; Barbuto, José Alexandre Marzagão ; Strauss, Bryan Eric
Fonte: Frontiers in Immunology. Unidades: ICB, FM
Assuntos: IMUNOLOGIA, ADENOVÍRUS, APOPTOSE, MELANOMA, IMUNOGENÉTICA, ONCOGENES, IMUNOTERAPIA, INTERFERONS, TRANSFERÊNCIA DE GENES, CAMUNDONGOS, CÉLULAS CULTIVADAS DE TUMOR, CÉLULAS DENDRÍTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERQUEIRA, Otto Luiz Dutra et al. Combined p14ARF and interferon-β gene transfer to the human melanoma cell line SK-MEL-147 promotes oncolysis and immune activation. Frontiers in Immunology, v. 11, p. 13 , 2020Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2020.576658. Acesso em: 04 jun. 2024.
APA
Cerqueira, O. L. D., Salomon, M. A. C., Cardoso, E. C., Tortelli Junior, T. C., Mendonça, S. A., Barbuto, J. A. M., & Strauss, B. E. (2020). Combined p14ARF and interferon-β gene transfer to the human melanoma cell line SK-MEL-147 promotes oncolysis and immune activation. Frontiers in Immunology, 11, 13 . doi:10.3389/fimmu.2020.576658
NLM
Cerqueira OLD, Salomon MAC, Cardoso EC, Tortelli Junior TC, Mendonça SA, Barbuto JAM, Strauss BE. Combined p14ARF and interferon-β gene transfer to the human melanoma cell line SK-MEL-147 promotes oncolysis and immune activation [Internet]. Frontiers in Immunology. 2020 ; 11 13 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.3389/fimmu.2020.576658
Vancouver
Cerqueira OLD, Salomon MAC, Cardoso EC, Tortelli Junior TC, Mendonça SA, Barbuto JAM, Strauss BE. Combined p14ARF and interferon-β gene transfer to the human melanoma cell line SK-MEL-147 promotes oncolysis and immune activation [Internet]. Frontiers in Immunology. 2020 ; 11 13 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.3389/fimmu.2020.576658
Artigo de periodico
Human NK cells prime inflammatory DC precursors to induce Tc17 differentiation (2020)
Salomon, Maria Alejandra Clavijo ; Salcedo, Rosalba; Roy, Soumen ; Neves, Rodrigo X. das; Dzutsev, Amiran ; Campos, Helioswilton Sales ; Borbely, Karen Steponavicius Cruz ; Silla, Lucia ; Orange, Jordan S. ; Mace, Emily M. ; Barbuto, José Alexandre Marzagão ; Trinchieri, Giorgio
Fonte: Blood Advances. Unidade: ICB
Assuntos: IMUNOLOGIA, CÉLULAS DENDRÍTICAS, INFLAMAÇÃO, INTERLEUCINAS, INTERFERONS, MONÓCITOS, IMUNOLOGIA CELULAR, ANTÍGENOS, DIFERENCIAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALOMON, Maria Alejandra Clavijo et al. Human NK cells prime inflammatory DC precursors to induce Tc17 differentiation. Blood Advances, v. 4, n. 16, p. 3990–4006, 2020Tradução . . Disponível em: https://doi.org/10.1182/bloodadvances.2020002084. Acesso em: 04 jun. 2024.
APA
Salomon, M. A. C., Salcedo, R., Roy, S., Neves, R. X. das, Dzutsev, A., Campos, H. S., et al. (2020). Human NK cells prime inflammatory DC precursors to induce Tc17 differentiation. Blood Advances, 4( 16), 3990–4006. doi:10.1182/bloodadvances.2020002084
NLM
Salomon MAC, Salcedo R, Roy S, Neves RX das, Dzutsev A, Campos HS, Borbely KSC, Silla L, Orange JS, Mace EM, Barbuto JAM, Trinchieri G. Human NK cells prime inflammatory DC precursors to induce Tc17 differentiation [Internet]. Blood Advances. 2020 ; 4( 16): 3990–4006.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1182/bloodadvances.2020002084
Vancouver
Salomon MAC, Salcedo R, Roy S, Neves RX das, Dzutsev A, Campos HS, Borbely KSC, Silla L, Orange JS, Mace EM, Barbuto JAM, Trinchieri G. Human NK cells prime inflammatory DC precursors to induce Tc17 differentiation [Internet]. Blood Advances. 2020 ; 4( 16): 3990–4006.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1182/bloodadvances.2020002084
Artigo de periodico
CD163+ tumor‐associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes (2020)
Ramos, Rodrigo Nalio; Rodriguez, Céline ; Hubert, Margaux ; Ardin, Maude; Treilleux, Isabelle ; Ries, Carola H.; Lavergne, Emilie ; Chabaud, Sylvie; Colombe, Amélie ; Trédan, Olivier ; Guedes, Henrique Gomes; Laginha, Fábio ; Richer, Wilfrid ; Piaggio, Eliane ; Barbuto, José Alexandre Marzagão ; Caux, Christophe ; Caux, Christine Ménétrier ; Vermare, Nathalie Bendriss
Fonte: Clinical & Translational Immunology. Unidade: ICB
Assuntos: IMUNOLOGIA, CITOMETRIA DE FLUXO, FENÓTIPOS, NEOPLASIAS MAMÁRIAS, CÉLULAS CULTIVADAS DE TUMOR, CITOCINAS, FÁRMACOS IMUNOSSUPRESSORES, MACRÓFAGOS, MONÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMOS, Rodrigo Nalio et al. CD163+ tumor‐associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes. Clinical & Translational Immunology, v. 9, p. 18 , 2020Tradução . . Disponível em: https://doi.org/10.1002/cti2.1108. Acesso em: 04 jun. 2024.
APA
Ramos, R. N., Rodriguez, C., Hubert, M., Ardin, M., Treilleux, I., Ries, C. H., et al. (2020). CD163+ tumor‐associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes. Clinical & Translational Immunology, 9, 18 . doi:10.1002/cti2.1108
NLM
Ramos RN, Rodriguez C, Hubert M, Ardin M, Treilleux I, Ries CH, Lavergne E, Chabaud S, Colombe A, Trédan O, Guedes HG, Laginha F, Richer W, Piaggio E, Barbuto JAM, Caux C, Caux CM, Vermare NB. CD163+ tumor‐associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes [Internet]. Clinical & Translational Immunology. 2020 ; 9 18 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.1002/cti2.1108
Vancouver
Ramos RN, Rodriguez C, Hubert M, Ardin M, Treilleux I, Ries CH, Lavergne E, Chabaud S, Colombe A, Trédan O, Guedes HG, Laginha F, Richer W, Piaggio E, Barbuto JAM, Caux C, Caux CM, Vermare NB. CD163+ tumor‐associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes [Internet]. Clinical & Translational Immunology. 2020 ; 9 18 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.1002/cti2.1108
Artigo de periodico
Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells (2018)
Fernandes, Thais Batista; Azevedo, Ricardo Alexandre de; Yang, Rosania; Teixeira, Sarah Fernandes; Trossini, Gustavo Henrique Goulart ; Barbuto, José Alexandre Marzagão ; Ferreira, Adilson Kleber; Parise Filho, Roberto
Fonte: Letters in Drug Design and Discovery. Unidades: FCF, ICB
Assuntos: APOPTOSE, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Thais Batista et al. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells. Letters in Drug Design and Discovery, v. 15, n. 12, p. 1288-1298, 2018Tradução . . Disponível em: https://doi.org/10.2174/1570180815666180321161513. Acesso em: 04 jun. 2024.
APA
Fernandes, T. B., Azevedo, R. A. de, Yang, R., Teixeira, S. F., Trossini, G. H. G., Barbuto, J. A. M., et al. (2018). Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells. Letters in Drug Design and Discovery, 15( 12), 1288-1298. doi:10.2174/1570180815666180321161513
NLM
Fernandes TB, Azevedo RA de, Yang R, Teixeira SF, Trossini GHG, Barbuto JAM, Ferreira AK, Parise Filho R. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells [Internet]. Letters in Drug Design and Discovery. 2018 ; 15( 12): 1288-1298.[citado 2024 jun. 04 ] Available from: https://doi.org/10.2174/1570180815666180321161513
Vancouver
Fernandes TB, Azevedo RA de, Yang R, Teixeira SF, Trossini GHG, Barbuto JAM, Ferreira AK, Parise Filho R. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells [Internet]. Letters in Drug Design and Discovery. 2018 ; 15( 12): 1288-1298.[citado 2024 jun. 04 ] Available from: https://doi.org/10.2174/1570180815666180321161513
Artigo de periodico
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy (2017)
Medrano, Ruan Felipe Vieira; Hunger, Aline; Mendonça, Samir Andrade; Barbuto, José Alexandre Marzagão ; Strauss, Bryan Eric
Fonte: Oncotarget. Unidade: ICB
Assuntos: IMUNOLOGIA, CÉLULAS MORTAS, CÉLULAS SANGUÍNEAS, INTERFERON TIPO I, ADJUVANTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDRANO, Ruan Felipe Vieira et al. Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy. Oncotarget, v. 8, n. 41, p. 71249-71284, 2017Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.1953. Acesso em: 04 jun. 2024.
APA
Medrano, R. F. V., Hunger, A., Mendonça, S. A., Barbuto, J. A. M., & Strauss, B. E. (2017). Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy. Oncotarget, 8( 41), 71249-71284. doi:10.18632/oncotarget.1953
NLM
Medrano RFV, Hunger A, Mendonça SA, Barbuto JAM, Strauss BE. Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy [Internet]. Oncotarget. 2017 ; 8( 41): 71249-71284.[citado 2024 jun. 04 ] Available from: https://doi.org/10.18632/oncotarget.1953
Vancouver
Medrano RFV, Hunger A, Mendonça SA, Barbuto JAM, Strauss BE. Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy [Internet]. Oncotarget. 2017 ; 8( 41): 71249-71284.[citado 2024 jun. 04 ] Available from: https://doi.org/10.18632/oncotarget.1953
Trabalho de evento-resumo
Estudo da obtenção de células híbridas dendríticastumorais caninas (2017)
Costa, Cícero Júlio Silva; Barbuto, José Alexandre Marzagão ; Gomes, Cristina de Oliveira Massoco Salles
Fonte: Resumos. Nome do evento: Simpósio Internacional de Iniciação Científica e Tecnológica da Universidade de São Paulo - SIICUSP. Unidades: ICB, FMVZ
Assuntos: CÃES, CÉLULAS DENDRÍTICAS, MELANOMA ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Cícero Júlio Silva e BARBUTO, José Alexandre Marzagão e GOMES, Cristina de Oliveira Massoco Salles. Estudo da obtenção de células híbridas dendríticastumorais caninas. 2017, Anais.. São Paulo: USP, 2017. Disponível em: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210. Acesso em: 04 jun. 2024.
APA
Costa, C. J. S., Barbuto, J. A. M., & Gomes, C. de O. M. S. (2017). Estudo da obtenção de células híbridas dendríticastumorais caninas. In Resumos. São Paulo: USP. Recuperado de https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
NLM
Costa CJS, Barbuto JAM, Gomes C de OMS. Estudo da obtenção de células híbridas dendríticastumorais caninas [Internet]. Resumos. 2017 ;[citado 2024 jun. 04 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
Vancouver
Costa CJS, Barbuto JAM, Gomes C de OMS. Estudo da obtenção de células híbridas dendríticastumorais caninas [Internet]. Resumos. 2017 ;[citado 2024 jun. 04 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
Artigo de periodico
Soluble uric acid activates the NLRP3 inflammasome (2017)
Braga, Tárcio Teodoro; Forni, Maria Fernanda; Costa, Matheus Correa; Ramos, Rodrigo Nalio; Barbuto, José Alexandre Marzagão ; Branco, Paola; Castoldi, Angela; Hiyane, Meire Ioshie; Davanso, Mariana Rodrigues; Latz, Eicke; Franklin, Bernardo S; Kowaltowski, Alicia Juliana ; Câmara, Niels Olsen Saraiva
Fonte: Scientific Reports. Unidades: ICB, IQ
Assuntos: ÁCIDO ÚRICO, MITOCÔNDRIAS, INFLAMAÇÃO, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAGA, Tárcio Teodoro et al. Soluble uric acid activates the NLRP3 inflammasome. Scientific Reports, v. 7, p. 1-14 art. 39884, 2017Tradução . . Disponível em: https://doi.org/10.1038/srep39884. Acesso em: 04 jun. 2024.
APA
Braga, T. T., Forni, M. F., Costa, M. C., Ramos, R. N., Barbuto, J. A. M., Branco, P., et al. (2017). Soluble uric acid activates the NLRP3 inflammasome. Scientific Reports, 7, 1-14 art. 39884. doi:10.1038/srep39884
NLM
Braga TT, Forni MF, Costa MC, Ramos RN, Barbuto JAM, Branco P, Castoldi A, Hiyane MI, Davanso MR, Latz E, Franklin BS, Kowaltowski AJ, Câmara NOS. Soluble uric acid activates the NLRP3 inflammasome [Internet]. Scientific Reports. 2017 ; 7 1-14 art. 39884.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1038/srep39884
Vancouver
Braga TT, Forni MF, Costa MC, Ramos RN, Barbuto JAM, Branco P, Castoldi A, Hiyane MI, Davanso MR, Latz E, Franklin BS, Kowaltowski AJ, Câmara NOS. Soluble uric acid activates the NLRP3 inflammasome [Internet]. Scientific Reports. 2017 ; 7 1-14 art. 39884.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1038/srep39884
Artigo de periodico
Paracoccidioidomycosis Associated With a Heterozygous STAT4 Mutation and Impaired IFN-γ Immunity (2017)
Schimke, Lena F; Hibbard, James; Martinez-Barricarte, Ruben; Khan, Taj Ali; Cavalcante, Ricardo de Souza; Oliveira-Junior, Edgar Borges de; França, Tábata Takahashi; Iqbal, Asif; Yamamoto, Guilherme; Arslanian, Christina; Feriotti, Claudia; Costa, Tânia Alves; Bustamante, Jacinta; Boisson-Dupuis, Stéphanie; Casanova, Jean-Laurent; Barbuto, José Alexandre Marzagão ; Zatz, Mayana ; Mendes, Rinaldo Poncio; Calich, Vera Lúcia Garcia; Ochs, Hans D; Torgerson, Troy R; Cabral-Marques, Otavio; Condino Neto, Antonio
Fonte: Journal of Infectious Diseases. Unidades: ICB, IB
Assuntos: PARACOCCIDIOIDOMICOSE, IMUNOLOGIA, MUTAÇÃO GENÉTICA, PREDISPOSIÇÃO GENÉTICA PARA DOENÇA, INFECÇÕES BACTERIANAS E MICOSES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHIMKE, Lena F et al. Paracoccidioidomycosis Associated With a Heterozygous STAT4 Mutation and Impaired IFN-γ Immunity. Journal of Infectious Diseases, v. 216, n. 12, p. 1623-1634, 2017Tradução . . Disponível em: https://doi.org/10.1093/infdis/jix522. Acesso em: 04 jun. 2024.
APA
Schimke, L. F., Hibbard, J., Martinez-Barricarte, R., Khan, T. A., Cavalcante, R. de S., Oliveira-Junior, E. B. de, et al. (2017). Paracoccidioidomycosis Associated With a Heterozygous STAT4 Mutation and Impaired IFN-γ Immunity. Journal of Infectious Diseases, 216( 12), 1623-1634. doi:10.1093/infdis/jix522
NLM
Schimke LF, Hibbard J, Martinez-Barricarte R, Khan TA, Cavalcante R de S, Oliveira-Junior EB de, França TT, Iqbal A, Yamamoto G, Arslanian C, Feriotti C, Costa TA, Bustamante J, Boisson-Dupuis S, Casanova J-L, Barbuto JAM, Zatz M, Mendes RP, Calich VLG, Ochs HD, Torgerson TR, Cabral-Marques O, Condino Neto A. Paracoccidioidomycosis Associated With a Heterozygous STAT4 Mutation and Impaired IFN-γ Immunity [Internet]. Journal of Infectious Diseases. 2017 ; 216( 12): 1623-1634.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1093/infdis/jix522
Vancouver
Schimke LF, Hibbard J, Martinez-Barricarte R, Khan TA, Cavalcante R de S, Oliveira-Junior EB de, França TT, Iqbal A, Yamamoto G, Arslanian C, Feriotti C, Costa TA, Bustamante J, Boisson-Dupuis S, Casanova J-L, Barbuto JAM, Zatz M, Mendes RP, Calich VLG, Ochs HD, Torgerson TR, Cabral-Marques O, Condino Neto A. Paracoccidioidomycosis Associated With a Heterozygous STAT4 Mutation and Impaired IFN-γ Immunity [Internet]. Journal of Infectious Diseases. 2017 ; 216( 12): 1623-1634.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1093/infdis/jix522
Artigo de periodico
Human CD40 ligand deficiency dysregulates the macrophage transcriptome causing functional defects that are improved by exogenous IFN-γ (2017)
Cabral-Marques, Otavio; Ramos, Rodrigo Nalio; Schimke, Lena Friederick; Khan, Taj Ali; Amaral, Eduardo Pinheiro; Bomfim, Caio César Barbosa; Reis Junior, Osvaldo; França, Tabata Takahashi; Kubo, Christina Arslanian; Lima, Joanna Darck Carola Correia; Weber, Cristina Worm; Ferreira, Janaíra Fernandes; Tavares, Fabiola Scancetti; Sun, Jing; Lima, Maria Regina D'Império ; Seelaender, Marília; Calich, Vera Lucia Garcia; Barbuto, José Alexandre Marzagão ; Costa-Carvalho, Beatriz Tavares; Riemekasten, Gabriela; Seminario, Gisela; Bezrodnik, Liliana; Notarangelo, Luigi; Torgerson, Troy R.; Ochs, Hans D.; Condino-Neto, Antonio
Fonte: Journal of Allergy and Clinical Immunology. Unidade: ICB
Assuntos: HISTOLOGIA, IMUNOLOGIA, MACRÓFAGOS, ADJUVANTES IMUNOLÓGICOS, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CABRAL-MARQUES, Otavio et al. Human CD40 ligand deficiency dysregulates the macrophage transcriptome causing functional defects that are improved by exogenous IFN-γ. Journal of Allergy and Clinical Immunology, v. 139, n. 3, p. 900-912, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.jaci.2016.07.018. Acesso em: 04 jun. 2024.
APA
Cabral-Marques, O., Ramos, R. N., Schimke, L. F., Khan, T. A., Amaral, E. P., Bomfim, C. C. B., et al. (2017). Human CD40 ligand deficiency dysregulates the macrophage transcriptome causing functional defects that are improved by exogenous IFN-γ. Journal of Allergy and Clinical Immunology, 139( 3), 900-912. doi:10.1016/j.jaci.2016.07.018
NLM
Cabral-Marques O, Ramos RN, Schimke LF, Khan TA, Amaral EP, Bomfim CCB, Reis Junior O, França TT, Kubo CA, Lima JDCC, Weber CW, Ferreira JF, Tavares FS, Sun J, Lima MRD'I, Seelaender M, Calich VLG, Barbuto JAM, Costa-Carvalho BT, Riemekasten G, Seminario G, Bezrodnik L, Notarangelo L, Torgerson TR, Ochs HD, Condino-Neto A. Human CD40 ligand deficiency dysregulates the macrophage transcriptome causing functional defects that are improved by exogenous IFN-γ [Internet]. Journal of Allergy and Clinical Immunology. 2017 ; 139( 3): 900-912.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.jaci.2016.07.018
Vancouver
Cabral-Marques O, Ramos RN, Schimke LF, Khan TA, Amaral EP, Bomfim CCB, Reis Junior O, França TT, Kubo CA, Lima JDCC, Weber CW, Ferreira JF, Tavares FS, Sun J, Lima MRD'I, Seelaender M, Calich VLG, Barbuto JAM, Costa-Carvalho BT, Riemekasten G, Seminario G, Bezrodnik L, Notarangelo L, Torgerson TR, Ochs HD, Condino-Neto A. Human CD40 ligand deficiency dysregulates the macrophage transcriptome causing functional defects that are improved by exogenous IFN-γ [Internet]. Journal of Allergy and Clinical Immunology. 2017 ; 139( 3): 900-912.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.jaci.2016.07.018

Unidades USP

ReP

Filtros

Tipo de material

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Editora

Nome do evento

País de publicação

Grupo de pesquisa

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos